QUALIBLOOD
F04
Description
QUALIblood provides the hospitals, pharmaceutical industries and universities with all analytical services for blood investigation.
Our dedicated team of experts is committed to delivering excellence in every aspect of our services, from meticulous bioanalytical assessments to comprehensive preclinical up to post market study management.
On top of that, our researchers have developed a new biomarker allowing to assess the risk of thrombosis linked to hormonal therapies such as contraception. This test is currently used by gynecologists to select the best pills for their patients.
We stand as pioneers, leveraging cutting-edge technologies and methodologies to ensure the highest standards of data integrity and reliability. Our mission is to empower pharmaceutical and biotechnology companies, academic institutions and healthcare organizations by providing them with the insights they need to advance medical research and improve patient outcomes
Hall
Hall2
Booth number
F04
Business sector
Website
www.qualiblood.eu
